Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Breast Cancer”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Study completedNCT01387373
What this trial is testing

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Who this might be right for
Metastatic Breast CancerLiver Metastases
Dorte Nielsen 14
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Large-scale testing (Phase 3)Study completedNCT01099436
What this trial is testing

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Borstkanker Onderzoek Groep 250
Testing effectiveness (Phase 2)Study completedNCT00951054
What this trial is testing

NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Nippon Kayaku Co., Ltd. 61
Large-scale testing (Phase 3)Study completedNCT00314977
What this trial is testing

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Radboud University Medical Center 200
Testing effectiveness (Phase 2)Ended earlyNCT00194792
What this trial is testing

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+3 more
University of Washington 28
Not applicableStudy completedNCT02685631
What this trial is testing

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Who this might be right for
Localized Non-Resectable Adult Liver Carcinoma
Vanderbilt-Ingram Cancer Center 1,653
Testing effectiveness (Phase 2)Ended earlyNCT05583110
What this trial is testing

Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerLocally Advanced HER2 Positive Breast Carcinoma
Spanish Breast Cancer Research Group 13
Testing effectiveness (Phase 2)Study completedNCT00617942
What this trial is testing

Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer

Who this might be right for
Breast Cancer
William Sikov MD 60
Not applicableWithdrawnNCT00466830
What this trial is testing

Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer

Who this might be right for
Breast CancerPainPsychosocial Effects of Cancer and Its Treatment
Institut Bergonié
Testing effectiveness (Phase 2)UnknownNCT01609127
What this trial is testing

Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer
Genta Incorporated 213
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableLooking for participantsNCT07218432
What this trial is testing

The TheraBionic P1 Device in Breast Cancer

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIA+2 more
Barbara Ann Karmanos Cancer Institute 24
Not applicableEnded earlyNCT05447910
What this trial is testing

Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaInvasive Breast CarcinomaResectable Breast Carcinoma
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT00723125
What this trial is testing

Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer

Who this might be right for
Breast Cancer
William Sikov MD 60
Early research (Phase 1)Study completedNCT01502592
What this trial is testing

Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer

Who this might be right for
Breast CancerInvasive Adenocarcinoma of the Breast
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT03815890
What this trial is testing

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 80
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT04301739
What this trial is testing

To Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer
Shanghai Henlius Biotech 522
Load More Results